Insights into the biologic and molecular abnormalities in adult acute lymphocytic leukemia

Hematology/Oncology Clinics of North America

Volumn 14, Issue 6, 2000, Pages 1267-1288

  Faderl, Stefan ^a   Albitar, Maher ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; CELL ADHESION MOLECULE; RAS PROTEIN;

ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; ANGIOGENESIS; CANCER GENETICS; CANCER THERAPY; CELL CYCLE; CHILD; CYTOGENETICS; DISEASE COURSE; DNA DAMAGE; HUMAN; LEUKEMOGENESIS; MOLECULAR BIOLOGY; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

EID: 0033634748     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70186-6     Document Type: Article

References (150)

1. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes
2. Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia
3. TEL-AML1 fusion in acute lymphoblastic leukaemia of adults. M.R.C. Adult Leukaemia Working Party
4. The pattern of mutational involvement of RAS genes in human hematologic malignancies determined by DNA amplification and direct sequencing
5. Expression of surface adhesion molecules CD54 (ICAM-1) and CD58 (LFA-3) in adult acute leukemia: Relationship with initial characteristics and prognosis
6. Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia
7. Cell anchorage and the cytoskeleton as partners in the growth factor-dependent cell cycle progression
8. RAS inhibitors in hematologic cancers: Biologic considerations and clinical applications
9. RAS and leukemia: From basic mechanisms to genedirected therapy
10. Autocrine interleukin-1beta production in leukemia: Evidence for the involvement of mutated RAS
11. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies
12. Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148)
13. Emerging concepts in the Ras superfamily of GTP-binding proteins
14. Regulators and effectors of Ras proteins
15. Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials
16. Biology and clinical significance of the TEL/AML1 rearrangement
17. Surface antigen phenotype can predict TEL-AML1 rearrangement in childhood B-precursor ALL: A Pediatric Oncology Group Study
18. Analysis of the mechanism of adhesion of precursor-B acute lymphoblastic leukemia cells to bone marrow fibroblasts
19. Analysis of the BCR-ABL protein in Philadelphia chromosome-positive adult acute lymphocytic leukemia
20. The role of ATM in DNA damage responses and cancer
21. Assignment of the gene for methylthioadenosine phosphorylase to human chromosome 9 by mouse-human somatic cell hybridization
22. Multiple tumor suppressor gene 1 inactivation is the most frequent alteration in T-cell lymphoblastic leukemia
23. Lymphoblastic leukemia with lymphomatous features associated with abnormalities of the short arm of chromosome 9
24. Deletions in the 13q14 locus in adult lymphoblastic leukemia: Rate of incidence and relevance
25. Integrins and signal transduction pathways: The road taken
26. Deletions and losses in chromosomes 5 and 7 in adult acute lymphocytic leukemia: Incidence, associations and implications
27. Induction of chronic myelogenous leukemia in mice: The p210(bcr/abl) gene of the Philadelphia chromosome
28. DNA damage-induced cell cycle checkpoints and DNA strand break repair in development and tumorigenesis
29. The tyrosine kinase inhibitor CGP57148B selectively inhibits the growth of BCR-ABL-positive cells
30. Inactivation of cyclin-dependent kinase inhibitor genes and development of human acute leukemias
31. Critical study of prognostic factors in childhood acute lymphoblastic leukemia: Differences in outcome are poorly explained by the most significant prognostic variables. Fralle group
32. Review of alterations of the cyclin-dependent kinase inhibitors: INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells
33. Cell adhesion receptors in lymphoma dissemination
34. Clinical efficacy and safety of an ABL specific tyrosine kinase inhibitor as targeted therapy for chronic myelogenous leukemia
35. Activity of an ABL specific tyrosine kinase inhibitor in patients with BCR-ABL positive acute leukemias, including chronic myelogenous leukemia in blast crisis
36. Heterogeneity in lineage derivation of Philadelphia-positive acute lymphoblastic leukemia expressing p190BCR-ABL or p210BCR-ABL: Determination by analysis of individual colonies with the polymerase chain reaction
37. Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia
38. Loss of heterozygosity (LOH) of chromosome 5 in adults with acute lymphoblastic leukemia and its clinical relevance
39. The prognostic significance of p16INK4a/p14ARF and p15INK4b deletions in adult acute lymphoblastic leukemia
40. Caspase 2 and caspase 3 as predictors of complete remission and survival in adults with acute lymphoblastic leukemia
41. The biology of chronic myeloid leukemia
42. Outcome of Philadelphia chromosome-positive adult acute lymphoblastic leukemia
43. Both TEL and AML-1 contribute repression domains to the t(12;21) fusion protein
44. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia
45. P13K: Downstream AKTion blocks apoptosis
46. Leukemogenesis by CBF oncoproteins
47. Farnesyltrasferase inhibitors: Ras research yields a potential cancer therapeutic
48. The potential of farnesyltransferase inhibitors as cancer chemotherapeutics
49. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia
50. The function of BCR/ABL and related proto-oncogenes
51. Cytogenetic abnormalities in adult acute lymphoblastic leukemia: Correlations with hematologic findings and outcome. A collaborative study of the Groupe Francais de Cytogenetique Hematologique
52. Hypermethylation of p16 and p15 genes and RB protein expression in acute leukemia
53. p16INK4A and p15INK4B gene deletions in primary leukemias
54. ATM gene deletion in patients with adult acute lymphoblastic leukemia
55. Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: A Pediatric Oncology Group study
56. Circulating soluble adhesion molecule levels in children with acute lymphoblastic leukaemia
57. Therapeutic intervention and signaling
58. Ultrastructural changes during adhesion and migration of pre-B lymphoid leukaemia cells within bone marrow stroma
59. TEL/AML1 fusion gene resulting from a cryptic t(12;21) is uncommon in adult patients with B-cell lineage ALL and CML lymphoblastic transformation
60. Evidence of increased angiogenesis in patients with acute myeloid leukemia
61. Integrins: Versatility, modulation, and signaling in cell adhesion
62. Methylation of the multi tumor suppressor gene-2 (MTS2, CDKN1, p15INK4B) in childhood acute lymphoblastic leukemia
63. Hyperdiploid acute lymphoblastic leukemia with 51 to 65 chromosomes: A distinct biological entity with a marked propensity to undergo apoptosis
64. Favorable prognosis associated with hyperdiploidy in children with acute lymphoblastic leukemia correlates with extra chromosome 6. A Pediatric Oncology Group study
65. The expression of the ras p21 oncoprotein in the bone marrow smears of children with acute leukemia
66. A cell cycle regulator potentially involved in genesis of many tumor types
67. Significance of the P210 versus P190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemia
68. Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia
69. Favorable prognosis of hyperdiploid common acute lymphoblastic leukemia may be explained by sensitivity to antimetabolites and other drugs: Results of an in vitro study
70. Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia
71. Homozygous deletion of the p16/MTS1 gene in pediatric acute lymphoblastic leukemia is associated with unfavorable clinical outcome
72. Rapid ATM-dependent phophorylation of MDM2 precedes p53 accumulation in response to DNA damage
73. Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation
74. Adhesion through the LFA-1 (CD11a/CD18)-ICAM-1 (CD54) and the VLA-4 (CD49d)-VCAM-1 (CD106) pathways prevents apoptosis of germinal center B cells
75. A novel c-abl protein product in Philadelphia-positive acute lymphblasti leukemia
76. Low frequency of TEL/AML1 in adult acute lymphoblastic leukemia
77. ATM: The product of the gene mutated in ataxia-telangiectasia
78. ATM: The protein encoded by the gene mutated in the radiosensitive syndrome ataxia-telangiectasia
79. Expression of integrins and examination of their adhesive function in normal and leukemic hematopoietic cells
80. 13q deletions in lymphoid malignancies
81. Inicidence of TEL/AML1 fusion in children with relapsed acute lymphoblastic leukemia
82. N-Ras gene point mutations in childhood acute lymphocytic leukemia correlate with a poor prognosis
83. Acquisition of p16(INK4A) and p15(INK4B) gene abnormalities between initial diagnosis and relapse in children with acute lymphoblastic leukemia
84. Adhesion of precursor-B acute lymphoblastic leukaemia cells to bone marrow stromal proteins
85. TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia
86. Enhanced expression of p16ink4a is associated with a poor prognosis in childhood acute lymphoblastic leukemia
87. Dichotomy of hyperdiploid acute lymphoblastic leukemia on the basis of the distribution of gained chromosomes
88. Selective homing of human leukemic B-cell precursors to specific lymphohematopoietic microenvironments in SCID mice: A role for the beta 1 integrin family surface adhesion molecules VLA-4 and VLA-4
89. Expression of intercellular adhesion molecule 1 (ICAM-1) in childhood acute lymphoblastic leukaemia: Correlation with clinical features and outcome
90. The controlling role of ATM in homologous recombinational repair of DNA damage
91. Molecular interactions between human B-cell progenitors and the bone marrow microenvironment
92. Molecular analysis of the 5q-syndrome
93. p16/MTS1/INK4A gene is frequently inactivated by hypermethylation in childhood acute lymphoblastic leukemia with 11q23 translocation
94. Rapid and reliable detection of N-ras mutations in acute lymphoblastic leukemia by melting curve analysis using LightCycler technology
95. Analysis of RAS oncogene mutations in human lymphoid malignancies
96. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
97. A minute chromosome in human chronic granulocytic leukemia
98. Universal inactivation of both p16 and p15 but not downstream components is an essential event in the pathogenesis of T-cell acute lymphoblastic leukemia
99. Hematopoiesis. How does it happen?
100. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia
101. Analysis of TEL proteins in human leukemias
102. The Ink4a tumor suppressor gene product, p19(Arf), interacts with MDM2 and neutralizes MDM2's inhibition of p53
103. Acute lymphoblastic leukemia in children
104. Bcr-Abl oncoproteins bind directly to activators of the Ras signaling pathway
105. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest
106. Low-molecular-weight GTP-binding proteins and leukocyte signal transduction
107. Hyperdiploid (47-50) acute lymphoblastic leukemia in children
108. The 12;21 translocation involving TEL and deletion of the other TEL allele: Two frequently associated alterations in childhood acute lymphoblastic leukemia
109. The vascular cell adhesion molecule (VCAM-1) is expressed on a subset of lymphoid and myeloid leukaemias
110. Ras and human tumors
111. Phosphatidylinositol-3-OH kinase as a direct target of Ras
112. The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion
113. ATM: A mediator of multiple responses to genotoxic stress
114. TEL gene rearrangement in acute lymphoblastic leukemia: A new genetic marker with prognostic significance
115. Low frequency of TEL-AML1 in relapsed acute lymphoblastic leukemia supports a favorable prognosis for this genetic subgroup
116. Anchorage dependence, integrins, and apoptosis
117. Adherence of normal and neoplastic human B cell precursors to the bone marrow microenvironment
118. Mantle cell lymphoma is characterized by inactivation of the ATM gene
119. Inicidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05- 92
120. Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukemia on MRC trial UKALL XA
121. Prognostic implications of chromosomal findings in acute lymphoblastic leukemia at diagnosis
122. TEL-AML1 fusion transcript in relapsed childhood acute lymphoblastic leukemia
123. Integrin signaling: The platelet paradigm
124. Hyperdiploidy (greater than 50 chromosomes) has the most favorable prognosis among the major karyotypic subgroups of childhood acute lymphoblastic leukemia
125. TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion pediatric ALL and defines a subgroup of patients with an excellent prognosis
126. Role of the cyclin-dependent kinase 4 and 6 inhibitor gene family p15, p 16, p18 and p19 in leukemia and lymphoma
127. Functional characterization of TEL/AML1 fusion protein in the regulation of human CR1 gene promoter
128. Ph positive acute lymphoblastic leukemia in adults: Molecular and clinical studies
129. High levels of the shed form of L-selectin are present in patients with acute leukemia and inhibit blast cell adhesion to activated endothelium
130. Cell cycle regulatory gene abnormalities are important determinants of leukemogenesis and disease biology in adult acute lymphoblastic leukemia
131. Prognostic significance of TEL/AML1 fusion transcript in childhood B-precursor acute lymphoblastic leukemia
132. Homozygous deletions at 9p21 in childhood acute lymphoblastic leukemia detected by microsatellite analysis
133. The ATM gene and susceptibility to childhood T-cell acute lymphoblastic leukemia
134. Identification of three distinct regions of deletion on the long arm of chromosome 11 in childhood acute lymphoblastic leukemia
135. Serum soluble CD44 in pediatric patients with acute leukemia
136. Chromosomal abnormalities and their clinical significance in acute lymphoblastic leukemia
137. Philadelphia chromosome positive adult acute lymphoblastic leukemia: Characteristics, prognostic factors and treatment outcome
138. Chromosomal localization of human leukocyte, fibroblast, and immune interferon genes by means of in situ hybridization
139. Detection and significance of bcr-abl mRNA transcripts and fusion proteins in Philadelphia-positive adult acute lymphoblastic leukemia
140. 5q-, twenty-five years later: A synopsis
141. Biology of chronic myelogenous leukemia
142. BCR/ABL p210 and p190 cause distinct leukemia in transgenic mice
143. Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: A Cancer and Leukemia Group B Study (8762)
144. Prospective karyotype analysis in adult acute lymphoblastic leukemia: The Cancer and Leukemia Group B experience
145. Accumulation of high levels of methotrexate polyglutamates in lymphoblasts from children with hyperdiploid (greater than 50 chromosomes) B-lineage acute lymphoblastic leukemia: A Pediatric Oncology Group study
146. Accumulation of methotrexate polyglutamates, ploidy and trisomies of both chromosomes 4 and 10 in lymphoblasts from children with B-progenitor cell acute lymphoblastic leukemia: A Pediatric Oncology Group Study
147. Structure and possible mechanisms of TEL-AML1 gene fusions in childhood acute lymphoblastic leukemia
148. Aberrant p15 promoter methylation in adult and childhood acute leukemias of nearly all morphologic subtypes: Potential prognostic implications
149. Mutational analysis of the N-ras gene in acute lymphoblastic leukemia: A study of 125 Japanese pediatric cases
150. Incidence and clinical significance of CDKN2/MTS1/P16ink4A and MTS2/P15ink4B gene deletions in childhood acute lymphoblastic leukemia